13F
← All fund report cards

BARROW HANLEY MEWHINNEY & STRAUSS LLC

13F equity value
$30.5B
Positions
377
Top 10 concentration
25.2%
Quarters / total new picks
32 / 896
13F equity value over time
$0M$34B$67B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.2% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 46.9% of quarters (excess t = -0.27, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-0.4%
t-stat
-0.27
Quarterly win rate
47%
Annualized excess
+0.4%
$1 → follow vs universe
$2.15 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 0.91620180630: follow 0.83620180930: follow 0.86720181231: follow 0.82520190331: follow 0.77020190630: follow 0.88220190930: follow 0.91620191231: follow 0.63620200331: follow 0.84120200630: follow 0.94620200930: follow 1.16220201231: follow 1.38920210331: follow 1.26820210630: follow 1.39420210930: follow 1.33420211231: follow 1.31920220331: follow 1.37920220630: follow 1.27420220930: follow 1.51320221231: follow 1.43820230331: follow 1.56920230630: follow 1.58520230930: follow 1.68720231231: follow 1.64720240331: follow 1.70620240630: follow 1.81020240930: follow 1.70720241231: follow 1.46520250331: follow 1.72720250630: follow 1.72420250930: follow 2.09720251231: follow 2.152 0.58 1.45 2.32 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 377 · 2026 Q1

Ticker Value Weight QoQ
MRK $952M
3.1%
HOLD
CVX $875M
2.9%
ADD
GEHC $846M
2.8%
ADD
CCL $767M
2.5%
HOLD
ETR $751M
2.5%
TRIM
PR $737M
2.4%
ADD
PNW $705M
2.3%
ADD
XOM $688M
2.3%
TRIM
MCHP $682M
2.2%
ADD
HPE $675M
2.2%
ADD
ENTG $642M
2.1%
TRIM
APD $637M
2.1%
ADD
FCX $578M
1.9%
ADD
KDP $576M
1.9%
ADD
BAC $547M
1.8%
TRIM
BRK/B $514M
1.7%
TRIM
PSA $510M
1.7%
ADD
PCG $509M
1.7%
ADD
FTV $508M
1.7%
ADD
AXTA $506M
1.7%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.